...
首页> 外文期刊>Bone marrow transplantation >High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities
【24h】

High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities

机译:瑞士不相关供体移植中的高分辨率HLA匹配:I类和II类错配的不同影响可能反映了对非免疫原性或免疫原性较弱的DRB1 / DQB1差异的选择

获取原文
获取原文并翻译 | 示例
           

摘要

Unrelated donor searches in Switzerland require high-resolution HLA typing for HLA-A/B/C/DRB1/DRB3,4/DQB1 loci. We evaluated this strategy accepting donors with >= 9/10 match. Of 802 unrelated donor transplants in 2000-2013, 570 were 10/10 matched, 31 were DRB3/4 mismatched, 261 were single-allele mismatched and 13 had 2 allele mismatches. Of the 261 single-allele disparities, 60 concerned HLA-A/-B, 55 HLA-C and 73 HLA-DRB1/-DQB1 loci. Transplants were reduced intensity conditioning (289, 36%), marrow (187, 23%), EBMT risk score was low in 39, intermediate I in 331, intermediate II in 333 and high in 99 patients. Five-year survival was 48 +/- 4%. HLA affected survival in the multivariate model adjusted for risk score. HLA-A/-B and HLA-C mismatches had twice the mortality risks, whereas HLA-DRB1/-DQB1 mismatches were similar to matched transplants. HLA-DRB3/4 mismatches were associated with a nonsignificant increased mortality risk. HLA-DRB3/4 mismatches had higher graft-versus-host disease and transplant-related mortality risks and lower relapse rates compared with matched transplants. We show significant effects of HLA class I, but not HLA class II, mismatches. The lack of impact of DRB1 disparities may be related to the lower immunogenicity of the DRB1*11:01/11:04 and DRB1*14:01/14:54 mismatches, representing 46% of DRB1 incompatibilities. These results support a matching algorithm that prioritizes mismatches considered as more permissive.
机译:在瑞士,不相关的捐赠者搜索要求对HLA-A / B / C / DRB1 / DRB3,4 / DQB1基因座进行高分辨率HLA分型。我们评估了该策略接受匹配度大于等于9/10的捐助者的情况。在2000-2013年间的802例无关的供体移植中,有570例与10/10匹配,有31例与DRB3 / 4错配,有261例与单等位基因错配,有13例有2种等位基因错配。在261个单等位基因差异中,有60个涉及HLA-A / -B,55个HLA-C和73个HLA-DRB1 / -DQB1位点。移植物的强度调节降低(289%,36%),骨髓降低(187%,23%),EBMT风险评分在39例中较低,在331例中为I,在333例中为II,在99例患者中较高。五年生存率为48 +/- 4%。在对风险评分进行调整后的多变量模型中,HLA影响生存。 HLA-A / -B和HLA-C错配具有两倍的死亡风险,而HLA-DRB1 / -DQB1错配与匹配的移植相似。 HLA-DRB3 / 4错配与死亡风险无显着增加有关。与匹配的移植物相比,HLA-DRB3 / 4错配具有更高的移植物抗宿主病和与移植物相关的死亡风险,并且复发率更低。我们显示出I类HLA失配的显着影响,但没有显示II类HLA的显着影响。 DRB1差异影响的缺乏可能与DRB1 * 11:01/11:04和DRB1 * 14:01/14:54错配的较低免疫原性有关,占DRB1不兼容的46%。这些结果支持一种匹配算法,该算法优先考虑被认为更宽松的不匹配。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号